J.P. Morgan analyst Anupam Rama maintained a Buy rating on Scholar Rock Holding (NASDAQ:SRRK) Corp on Friday, setting a price target of $55, which is approximately 86.19% above the present share price of $29.54.
Rama expects Scholar Rock Holding Corp to post earnings per share (EPS) of -$1.02 for the fourth quarter of 2021.
The current consensus among 3 TipRanks analysts is for a Strong Buy rating of shares in Scholar Rock Holding, with an average price target of $61.67.
The analysts price targets range from a high of $74 to a low of $55.
In its latest earnings report, released on 09/30/2021, the company reported a quarterly revenue of $5.46 million and a net profit of -$37.08 million. The company's market cap is $1.04 billion.
According to TipRanks.com, J.P. Morgan analyst Anupam Rama is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 6.6% and a 44.24% success rate.
Scholar Rock Holding Corp. is a biopharmaceutical company, which engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.